How is Brexanolone administered?

Brexanolone is administered via a continuous intravenous (IV) infusion. This method is essential as it allows for a stable delivery of the medication over a set period, which is necessary for its effectiveness in treating postpartum depression. Continuous infusion helps maintain an adequate level of the drug in the bloodstream, which is crucial for maximizing therapeutic benefits while minimizing potential side effects.

Intravenous administration, in general, is preferred for medications that require rapid onset of action or precise control over dosage, which is particularly important for a condition like postpartum depression that may require immediate intervention. Brexanolone is specifically designed to be delivered in this manner to optimize its pharmacological effects.